Search research articles
Contact Us
Filters
Showing results (1-10 of 203) with videos related to
Page
of 21
Sort By:
Ryumachi. [Rheumatism]
|
February 24, 2001
[Origin of the diversity and similarity of pathological manifestations of collagen disease: lessons from murine models in an aspect of pathogenomics]
M Nose
Ryumachi. [Rheumatism]
|
December 1, 1988
[Action mechanism of cyclosporin A, immunomodulator in the treatment of MRL/lpr lupus mice]
M Nose
European Journal of Immunology
|
November 1, 1989
Substitution of asparagine324 with aspartic acid in the Fc portion of mouse antibodies reduces their capacity for C1q binding
M Nose, T Leanderson
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1990
Inhibition of processing of asparagine-linked carbohydrate chains on IgG2a by using swainsonine has no influence upon antibody effector functions in vitro
M Nose, B Heyman
Ryumachi. [Rheumatism]
|
April 1, 1986
[Lupus mice and arteritis]
M Nose, M Kyogoku
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1983
Biological significance of carbohydrate chains on monoclonal antibodies
M Nose, H Wigzell
Experimental Cell Biology
|
January 1, 1979
Role of soluble cytotoxic factor in concanavalin A-induced cellular cytotoxicity to rabbit erythrocytes
M Nose, M Kyogoku
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme
|
January 1, 1990
[Molecular aspects of autoimmune disease animal model MRL/lpr mice]
M Nose, M Kyogoku
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
August 1, 1994
[Animal models for intractable vasculitis: significance of genetic background]
M R Ito, M Nose
International Reviews of Immunology
|
October 4, 2000
Genetic basis of the complex pathological manifestations of collagen disease: lessons from MRL/lpr and related mouse models
M Nose, M Nishihara, H Fujii
Page
of 21
Search research articles
Search
Showing results (1-10 of 203) with videos related to
Sort By:
Page
of 21
Ryumachi. [Rheumatism]
|
February 24, 2001
[Origin of the diversity and similarity of pathological manifestations of collagen disease: lessons from murine models in an aspect of pathogenomics]
M Nose
Ryumachi. [Rheumatism]
|
December 1, 1988
[Action mechanism of cyclosporin A, immunomodulator in the treatment of MRL/lpr lupus mice]
M Nose
European Journal of Immunology
|
November 1, 1989
Substitution of asparagine324 with aspartic acid in the Fc portion of mouse antibodies reduces their capacity for C1q binding
M Nose, T Leanderson
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1990
Inhibition of processing of asparagine-linked carbohydrate chains on IgG2a by using swainsonine has no influence upon antibody effector functions in vitro
M Nose, B Heyman
Ryumachi. [Rheumatism]
|
April 1, 1986
[Lupus mice and arteritis]
M Nose, M Kyogoku
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1983
Biological significance of carbohydrate chains on monoclonal antibodies
M Nose, H Wigzell
Experimental Cell Biology
|
January 1, 1979
Role of soluble cytotoxic factor in concanavalin A-induced cellular cytotoxicity to rabbit erythrocytes
M Nose, M Kyogoku
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme
|
January 1, 1990
[Molecular aspects of autoimmune disease animal model MRL/lpr mice]
M Nose, M Kyogoku
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
August 1, 1994
[Animal models for intractable vasculitis: significance of genetic background]
M R Ito, M Nose
International Reviews of Immunology
|
October 4, 2000
Genetic basis of the complex pathological manifestations of collagen disease: lessons from MRL/lpr and related mouse models
M Nose, M Nishihara, H Fujii
Page
of 21